Reply to letter that comments on 'Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy'
Contributeurs/tricesPompe, R S; Von Bueren, André
Publié dansEuropean journal of cancer, vol. 56, p. 181-182
Date de publication2016-03
Date de mise en ligne2016-01-13
Mots-clés
- Antineoplastic Combined Chemotherapy Protocols / therapeutic use
- Cerebellar Neoplasms / therapy
- Female
- Humans
- Male
- Medulloblastoma / therapy
Structure d'affiliation Pas une publication de l'UNIGE
Citation (format ISO)
POMPE, R S et al. Reply to letter that comments on “Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy”. In: European journal of cancer, 2016, vol. 56, p. 181–182. doi: 10.1016/j.ejca.2015.11.011
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:157193
- DOI : 10.1016/j.ejca.2015.11.011
- PMID : 26774521
ISSN du journal0959-8049
